Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla Stephens

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2020
Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI RegistryJudith Sanabria-Cabrera, Rocío Sanjuán-Jiménez, Encarnación Clavijo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI RegistryEinar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Annals of Hepatology|June 20, 2012
Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiativeFernando Bessone, Nelia Hernandez, Milagros Dávalos, et al.
Clinical Pharmacology and Therapeutics|September 20, 2021
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping StudyAlejandro Cueto-Sanchez, Hao Niu, Enrique Del Campo-Herrera, et al.
Gastroenterology|April 8, 2014
Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injuryMercedes Robles-Diaz, M Isabel Lucena, Neil Kaplowitz, et al.
British Journal of Clinical Pharmacology|March 25, 2023
Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damageAlejandro Cueto-Sánchez, Hao Niu, Ismael Álvarez-Álvarez, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injuryM Isabel Lucena, Elena García-Martín, Raúl J Andrade, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 25, 2015
Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 casesFernando Bessone, M I Lucena, Marcelo G Roma, et al.
Archives of Toxicology|December 5, 2023
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registriesInmaculada Medina-Cáliz, Judith Sanabria-Cabrera, Marina Villanueva-Paz, et al.
Archives of Toxicology|November 23, 2022
Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registriesFernando Bessone, Antonella Ferrari, Nelia Hernandez, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2020
Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI RegistryJudith Sanabria-Cabrera, Rocío Sanjuán-Jiménez, Encarnación Clavijo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2022
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI RegistryEinar S Björnsson, Camilla Stephens, Edmond Atallah, et al.
Annals of Hepatology|June 20, 2012
Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiativeFernando Bessone, Nelia Hernandez, Milagros Dávalos, et al.
Clinical Pharmacology and Therapeutics|September 20, 2021
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping StudyAlejandro Cueto-Sanchez, Hao Niu, Enrique Del Campo-Herrera, et al.
Gastroenterology|April 8, 2014
Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injuryMercedes Robles-Diaz, M Isabel Lucena, Neil Kaplowitz, et al.
British Journal of Clinical Pharmacology|March 25, 2023
Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damageAlejandro Cueto-Sánchez, Hao Niu, Ismael Álvarez-Álvarez, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injuryM Isabel Lucena, Elena García-Martín, Raúl J Andrade, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 25, 2015
Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 casesFernando Bessone, M I Lucena, Marcelo G Roma, et al.
Archives of Toxicology|December 5, 2023
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registriesInmaculada Medina-Cáliz, Judith Sanabria-Cabrera, Marina Villanueva-Paz, et al.
Archives of Toxicology|November 23, 2022
Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registriesFernando Bessone, Antonella Ferrari, Nelia Hernandez, et al.
Pageof 6